当前位置: X-MOL 学术BMJ Open › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Description of symptom course in a telemedicine monitoring clinic for acute symptomatic COVID-19: a retrospective cohort study
BMJ Open ( IF 2.9 ) Pub Date : 2021-03-01 , DOI: 10.1136/bmjopen-2020-044154
James B O'Keefe , Elizabeth J Tong , Ghazala D O'Keefe , David C Tong

Objective Describe the disease course in a cohort of outpatients with COVID-19 and evaluate factors predicting duration of symptoms. Design Retrospective cohort study. Setting Telemedicine clinic at a large medical system in Atlanta, Georgia. Participants 337 patients with acute COVID-19. Exclusion criteria included intake visit more than 10 days after symptom onset and hospitalisation prior to intake visit. Main outcome measures Symptom duration in days. Results Common symptoms at intake visit are upper respiratory (73% cough, 55% loss of smell or taste, 57% sinus congestion, 32% sore throat) and systemic (66% headache, 64% body aches, 53% chills, 30% dizziness, 36% fever). Day of symptom onset was earliest for systemic and upper respiratory symptoms (median onset day 1 for both), followed by lower respiratory symptoms (day 3, 95% CI 2 to 4), with later onset of gastrointestinal symptoms (day 4, 95% CI 3 to 5), when present. Cough had the longest duration when present with median 17 days (95% CI 15 to 21), with 42% not resolved at final visit. Loss of smell or taste had the second longest duration with 14 days (95% CI 12 to 17), with 38% not resolved at final visit. Initial symptom severity is a significant predictor of symptom duration (p<0.01 for multiple symptoms). Conclusions COVID-19 illness in outpatients follows a pattern of progression from systemic symptoms to lower respiratory symptoms and persistent symptoms are common across categories. Initial symptom severity is a significant predictor of disease duration for most considered symptoms.

中文翻译:

远程症状监测COVID-19的远程医疗监测诊所中症状过程的描述:一项回顾性队列研究

目的描述一组COVID-19门诊患者的病程,并评估预测症状持续时间的因素。设计回顾性队列研究。在佐治亚州亚特兰大的大型医疗系统中设置远程医疗诊所。参与者337例急性COVID-19患者。排除标准包括症状发作后超过10天的就诊访视和就诊前住院。主要结局指标症状持续时间(以天为单位)。结果就诊时的常见症状是上呼吸道(73%咳嗽,55%的气味或味觉丧失,57%鼻窦充血,32%喉咙痛)和全身性(66%头痛,64%身体疼痛,53%畏寒,30%头晕,发烧36%)。症状发作的一天最早出现于全身和上呼吸道症状(两者均在中位发病的第1天),随后是下呼吸道症状(第3天,95%CI 2至4),出现胃肠道症状以后(第4天,95%CI 3至5)。咳嗽的持续时间最长,中位数为17天(95%CI为15至21),最后一次就诊时未解决为42%。嗅觉或味觉丧失的持续时间第二长,为14天(95%CI为12至17),其中38%在最终访视时仍未解决。最初的症状严重程度是症状持续时间的重要预测指标(对于多种症状,p <0.01)。结论门诊患者的COVID-19疾病遵循从全身症状向下呼吸道症状发展的模式,持续性症状在各个类别中都很常见。最初的症状严重程度是大多数考虑的症状的持续时间的重要预测指标。咳嗽的持续时间最长,中位数为17天(95%CI为15至21),最后一次就诊时未解决为42%。嗅觉或味觉丧失的持续时间第二长,为14天(95%CI为12至17),其中38%在最终访视时仍未解决。最初的症状严重程度是症状持续时间的重要预测指标(对于多种症状,p <0.01)。结论门诊患者的COVID-19疾病遵循从全身症状向下呼吸道症状发展的模式,持续性症状在各个类别中都很常见。最初的症状严重程度是大多数考虑的症状的持续时间的重要预测指标。咳嗽的持续时间最长,中位数为17天(95%CI为15至21),最后一次就诊时未解决为42%。嗅觉或味觉丧失的持续时间第二长,为14天(95%CI为12至17),其中38%在最终访视时仍未解决。最初的症状严重程度是症状持续时间的重要预测指标(对于多种症状,p <0.01)。结论门诊患者的COVID-19疾病遵循从全身症状向下呼吸道症状发展的模式,持续性症状在各个类别中都很常见。最初的症状严重程度是大多数考虑的症状的持续时间的重要预测指标。最初的症状严重程度是症状持续时间的重要预测指标(对于多种症状,p <0.01)。结论门诊患者的COVID-19疾病遵循从全身症状向下呼吸道症状发展的模式,持续性症状在各个类别中都很常见。最初的症状严重程度是大多数考虑的症状的持续时间的重要预测指标。最初的症状严重程度是症状持续时间的重要预测指标(对于多种症状,p <0.01)。结论门诊患者的COVID-19疾病遵循从全身症状向下呼吸道症状发展的模式,持续性症状在各个类别中都很常见。最初的症状严重程度是大多数考虑的症状的持续时间的重要预测指标。
更新日期:2021-03-05
down
wechat
bug